Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.98 USD | +1.23% | +0.40% | -10.17% |
05-21 | Lineage Cell Therapeutics, Inc. Announces Updates to 2nd Annual Spinal Cord Injury Investor Symposium | CI |
05-09 | Transcript : Lineage Cell Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.17% | 183M | |
+47.43% | 56.87B | |
+37.15% | 39.72B | |
-6.33% | 39.27B | |
-6.90% | 28.73B | |
+13.40% | 26.21B | |
-16.44% | 19.79B | |
+32.37% | 12.28B | |
+28.19% | 12.23B | |
+0.38% | 12.12B |
- Stock Market
- Equities
- LCTX Stock
- News Lineage Cell Therapeutics, Inc.
- BioTime, Inc. Appoints Chase C. Leavitt as General Counsel and Corporate Secretary